Dr. Schuster received his M.D. at Washington University, St. Louis in 1977. He was an intern, resident, and chief resident in Internal Medicine at the University of Washington, Seattle (Robert G. Petersdorf and Philip Fialkow, chairs) and a renal fellow at Southwestern Medical School, Dallas (Harry Jacobson, lab director; Donald W. Seldin, chair). His first faculty position was at the University of Iowa, Iowa City (Francois Abboud, chair). In 1988, he moved to the Albert Einstein College of Medicine in the Bronx (James Scheuer, chair) where he became chief of the Einstein Renal Division in 1992 and chief of the Unified Renal Division (Einstein + Montefiore hospital) in 1998. He was vice-chairman for research from 2000-2002.
Since 2002, he has been Baumritter Professor and University Chairman of the Department of Medicine at Einstein and at Montefiore Medical Center. The Department has ~270 full-time and ~750 voluntary faculty members. It receives ~$40 million annually in NIH dollars, generates clinical practice collections of ~$40 million annually, and manages a hospital budget of ~$25 million annually. The Department administers the fifth largest Internal Medicine house staff training program in the country and accounts for over half of Montefiore's hospital admissions. Since becoming Chairman, Dr. Schuster and his team have significantly exapnded the medical practice, and have simultaneously created the basis for additional investment and growth through attention to the "revenue cycle" (i.e. billings & collections). In part as a result of recruiting new physician-scientists, the Department's grant income increased by 36% between 2002-2005 (the comparable NIH extramural growth rate was 27%). Since 2002, Dr. Schuster and his colleagues in the Department have recruited/appointed six division chiefs; founded the first Einstein Division of General Internal Medicine, which is focused on expanding departmental "dry bench" research; expanded the teaching hospitalist program to an additional campus; and created & launched a performance/RVU-based compensation plan for the clinician-educators. To communicate to a far-flung and complex academic entity, Dr. Schuster writes and sends a weekly email departmental newsletter to over 800 recipients.
Scientifically, Dr. Schuster has focused for 25 years on vasoactive hormones and epithelial transport. His laboratory was the first to show that angiotensin II directly modulates fluid reabsorption by the proximal tubule. For a decade, he worked in acid-base physiology, characterizing the respective transporters of renal collecting duct a and b intercalated cells. In 1995, his laboratory discovered the prostaglandin (PG) transporter "PGT", a finding he has extended to human and mouse genetics, zebrafish, and drug discovery. His laboratory has advanced the hypothesis that PG signaling is akin to neuronal signaling, i.e. the signaling molecule is released and then taken up again by the same cell. Because PGT regulates the expression of, and signaling via, PG receptors, it comprises a new therapeutic target for modulating prostanoid signaling. The NIH has continuously funded his research program since 1983. He is currently the PI on an R01 in its 11th year, funded through 2011, and an NIH OÌBrien Kidney Center, funded through 2008. In recognition of his research accomplishments, he was elected to the American Society for Clinical Investigation (1992) and the Association of American Physicians (1998).
Dr. Schuster is active in clinical medicine and teaching. He serves as the Renal Consult Service attending physician for two months each year; is a frequent discussant of clinical cases with the house staff ("morning report" and "chief of service rounds"); and regularly lectures on renal physiology, pathophysiology, and disease to the Einstein medical students, MD-PhD students, and renal fellows.
Kanai,N Lu,R Satriano,J Bao,Y Wolkoff,AW Schuster,VL. Identification and characterization of a prostaglandin transporter. Science 268: 866-869, 1995.
Itoh,S Lu,R Bao,Y Morrow,JD Roberts,LJ Schuster,VL. Structural determinants of substrates for the prostaglandin transporter "PGT". Mol Pharm 50: 736-742, 1996.
Lu,R Kanai,N Bao,Y Schuster,VL. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA "hPGT". J Clin Invest 98: 1142-1149, 1996.
Schuster,VL Lu,R Coca-Prados,M. Identification and characterization of a prostaglandin transporter widely-expressed in ocular and other secretory epithelia. Survey Ophthalmol 41: S41-S45, 1997.
Schuster,VL. Molecular mechanisms of prostaglandin transport. Ann Rev Physiol 60: 221-242, 1998.
Chan,B Satriano,JA Pucci,M Schuster,VL. Mechanism of PGE2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT". J Biol Chem 273: 6689-6697, 1998.
Lu,R Schuster,VL. Molecular cloning of the gene for the human prostaglandin transporter hPGT: Gene organization, promoter activity, and chromosomal localization. Biochem Biophys Res Comm 246: 805-812, 1998.
Pucci,M Bao,Y Chan,B Itoh,S Lu,R Copeland,NG Gilbert,DA Jenkins,NA Schuster,VL. Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities. Am J Physiol (Regulatory) 277: R734-R741, 1999.
Chan,BS Satriano,JA Schuster,VL. Mapping the substrate binding site of the prostaglandin transporter PGT by cysteine scanning mutagenesis. J Biol Chem 274: 25564-25570, 1999.
Schuster,VL Itoh,S Andrews,SW Chen,J Kedzie,KM Krauss,HA Woodward,DF. Structural requirements for binding of prostaglandins to the prostaglandin FP receptor versus the prostaglandin transporter PGT. Mol Pharmacol 58: 1511-1516, 2000.
Endo,S Nomura,T Chan,BS Lu,R Pucci,ML Bao,Y Schuster,VL. Expression of PGT in MDCK cell monolayers: polarized apical localization and induction of active PG transport. Am J Physiol 282: F618-F622, 2002
Bao,Y Pucci,ML Chan,BS Lu,R Itoh,S Schuster,VL. Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am J Physiol (Renal) 282: F1103-1110, 2002.
Chan, BS Endo,S Kanai,N Schuster,VL. Identification of lactate as a substrate and a driving force for prostanoid transport by the prostaglandin transporter PGT. Am J Physiol (Renal) 282: F1097-1102, 2002.
van der Zwaag,B Verzijl,HTFM Beltran-Valero de Bernabe,D Schuster,VL van Bokhoven,H Kremer,H van Reen,M Wichers, GH Brunner,HG Padberg,GW. Mutation analysis in the candidate Mbius syndrome genes PGT and GATA2 on chromosome 3, and EGR2 on chromosome 10. J Med Genetics 39: e30, 2002
Chan,BS Bao,Y Schuster,VL. The role of conserved transmembrane cationic amino acids in the prostaglandin transporter PGT. Biochemistry 41: 9215-9221, 2002.
Schuster,VL. Prostaglandin transport. Prostaglandins and Other Lipid Mediators: 68-69: 633-647, 2002.
Nomura, T Lu,R Pucci,ML Schuster,VL. The two-step model of prostaglandin signal termination: in vitro reconstitution with the transporter PGT and prostaglandin 15 dehydrogenase. Molecular Pharmacology 65: 973-978, 2004.
Pucci,ML Chakkalakkal,B Liclican,EL Leedom,A Schuster,VL Abraham,NG. Augmented Heme Oxygenase-1 Induces Prostaglandin Uptake via the Prostaglandin Transporter in Micro-vascular Endothelial Cells. Biochem Biophys Res Commun. 323:1299-1305, 2004.
Nomura,T Chang,H-Y Lu,R Hankin,J Murphy,Rc Schuster,VL. Prostaglandin signaling in the renal collecting duct: release, reuptake, and oxidation in the same cell. J Biol Chem 280: 28424-28429, 2005.
Pucci,ML Endo,S Nomura,T Lu,R Khine,C Chan,B Bao,Y Schuster,VL. Coordinate control of prostaglandin E2 synthesis and reuptake by hyperosmolarity in renal medullary interstitial cells. Am J Physiology (Renal) 290: F641-F649, 2006
Chi,Y Khersonsky,SM Chang-Y-T Schuster,VL. Identification of a new class of PGT inhibitors and their biological effects on PGE2 transport. J Pharmacol Exp Therapeutics 316: 1346-1350, 2006
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.